Current role
Steven L. Hoerter
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Steven L. Hoerter
MBX Biosciences, Inc. reported in an 8-K filed April 7, 2025 that Steven L. Hoerter was appointed director, effective April 7, 2025.
“Effective as of April 7, 2025, the board of directors (the "Board") of MBX Biosciences, Inc. (the "Company"), upon the recommendation of the Nominating and Corporate Governance Committee of the Board (the "NCG Committee"), appointed Steven L. Hoerter as a director of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
MBX Biosciences, Inc. (MBX)
Proxy statement
CurrentStart not stated–present
-
Start not stated–2025-04-23
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at MBX Biosciences, Inc.
Other people whose current roles at this company are on record from its filings.
- Steven Hoerter CEO, Chairman
- John Smither CFO
- Ed Mathers Board Member
- Edward T. Mathers Board Member
- Laurie Stelzer Board Member
- Ora Pescovitz Board Member
- P. Kent Hawryluk Board Member
- Patrick J. Heron Board Member
- Steven Ryder Board Member
- Tiba Aynechi Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.